“Snake-oil,” “quack medicine,” and “industrially cultured organisms:” biovalue and the commercialization of human microbiome research [Book Review]
David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
BMC Medical Ethics 13 (1):28- (2012)
Background Continued advances in human microbiome research and technologies raise a number of ethical, legal, and social challenges. These challenges are associated not only with the conduct of the research, but also with broader implications, such as the production and distribution of commercial products promising maintenance or restoration of good physical health and disease prevention. In this article, we document several ethical, legal, and social challenges associated with the commercialization of human microbiome research, focusing particularly on how this research is mobilized within economic markets for new public health uses. Methods We conducted in-depth, semi-structured interviews (2009–2010) with 63 scientists, researchers, and National Institutes of Health project leaders (“investigators”) involved with human microbiome research. Interviews explored a range of ethical, legal, and social dimensions of human microbiome research, including investigators’ perspectives on commercialization. Using thematic content analysis, we identified and analyzed emergent themes and patterns. Results Investigators discussed the commercialization of human microbiome research in terms of (1) commercialization, probiotics, and issues of safety, (2) public awareness of the benefits and risks of dietary supplements, and (3) regulation. Conclusion The prevailing theme of ethical, legal, social concern focused on the need to find a balance between the marketplace, scientific research, and the public’s health. The themes we identified are intended to serve as points for discussions about the relationship between scientific research and the manufacture and distribution of over-the-counter dietary supplements in the United States
|Keywords||Commercialization Human microbiome Ethical legal and social implications (ELSI) Dietary supplements Qualitative research|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library||
References found in this work BETA
Glen I. Spielmans & Peter I. Parry (2010). From Evidence-Based Medicine to Marketing-Based Medicine: Evidence From Internal Industry Documents. [REVIEW] Journal of Bioethical Inquiry 7 (1):13-29.
Citations of this work BETA
No citations found.
Similar books and articles
Christian Lenk, Nils Hoppe, Katharian Beier & Claudia Wiesemann (eds.) (2011). Human Tissue Research. A European Perspective on the Ethical and Legal Challenges. Oxford University Press.
David N. Weisstub (ed.) (1998). Research on Human Subjects: Ethics, Law, and Social Policy. Pergamon.
David B. Resnik (2002). The Commercialization of Human Stem Cells: Ethical and Policy Issues. [REVIEW] Health Care Analysis 10 (2):127-154.
Vincent di Norcia (2005). Intellectual Property and the Commercialization of Research and Development. Science and Engineering Ethics 11 (2):203-219.
Vincent Norcia (2005). Intellectual Property and the Commercialization of Research and Development. Science and Engineering Ethics 11 (2):203-219.
Gail E. Henderson, Eric T. Juengst, Nancy M. P. King, Kristine Kuczynski & Marsha Michie (2012). What Research Ethics Should Learn From Genomics and Society Research: Lessons From the ELSI Congress of 2011. Journal of Law, Medicine and Ethics 40 (4):1008-1024.
Ezekiel J. Emanuel (ed.) (2003). Ethical and Regulatory Aspects of Clinical Research: Readings and Commentary. Johns Hopkins University Press.
Anna C. Mastroianni, Ruth R. Faden & Daniel D. Federman (eds.) (1994). Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies. National Academy Press.
Adil E. Shamoo (2009). Responsible Conduct of Research. Oxford University Press.
David B. Resnik (2012). Responsible Conduct in Nanomedicine Research: Environmental Concerns Beyond the Common Rule. Journal of Law, Medicine and Ethics 40 (4):848-855.
Patricia A. Marshall (2005). Human Rights,Cultural Pluralism, and International Health Research. Theoretical Medicine and Bioethics 26 (6):529-557.
Paul M. McNeill (1993). The Ethics and Politics of Human Experimentation. Cambridge University Press.
Keith Bauer, Sara Taub & Kayhan Parsi (2004). Ethical Issues in Tissue Banking for Research: A Brief Review of Existing Organizational Policies. Theoretical Medicine and Bioethics 25 (2):113-142.
Iain Hay (ed.) (2000). Qualitative Research Methods in Human Geography. Oxford University Press.
Sorry, there are not enough data points to plot this chart.
Added to index2012-11-01
Total downloads3 ( #224,136 of 1,089,063 )
Recent downloads (6 months)1 ( #69,801 of 1,089,063 )
How can I increase my downloads?